30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Sherman Matthew L

Insider profile

Performance

Overall performance
2.7

Performance over holding periods
2.7
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 67% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Sherman Matthew L's trades of Deciphera Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-20 2024-02-16 S Sale
19,010 +24.4%
306.65
US$4,919,932
19,010 +24.4% 306.65 US$4,919,932
2024-01-18 2024-01-16 S Sale
15,828 +45.7%
216.47
US$2,097,533
15,828 +45.7% 216.47 US$2,097,533
2023-12-14 2023-12-13 S Sale
11,270 +19.3%
406.58
US$4,690,148
11,270 +19.3% 406.58 US$4,690,148
2023-10-31 2023-10-30 S Sale
2,360 -2.5%
12.02
US$28,362
2,360 -2.5% 12.02 US$28,362
2023-10-04 2023-10-02 S Sale
2,942 -3.4%
12.68
US$37,305
2,942 -3.4% 12.68 US$37,305
2023-06-21 2023-06-16 PlS Planned sale
1,655 -1.9%
14.40
US$23,835
1,655 -1.9% 14.40 US$23,835
2023-02-17 2023-02-16 S Sale
971 -1.1%
15.10
US$14,661
971 -1.1% 15.10 US$14,661
2023-01-19 2023-01-17 PlS Planned sale
2,403 -3.2%
21.24
US$51,043
2,403 -3.2% 21.24 US$51,043
2022-10-05 2022-10-03 S Sale
2,587 -3.4%
18.73
US$48,455
2,587 -3.4% 18.73 US$48,455
2022-06-21 2022-06-16 PlS Planned sale
1,768 -2.2%
10.75
US$19,006
1,768 -2.2% 10.75 US$19,006
2022-02-18 2022-02-16 S Sale
984 -1.3%
9.05
US$8,905
984 -1.3% 9.05 US$8,905
2021-10-06 2021-10-04 PlS Planned sale
2,659 -5.5%
33.17
US$88,199
2,659 -5.5% 33.17 US$88,199
2021-02-18 2021-02-16 S Sale
132 -0.4%
48.87
US$6,451
132 -0.4% 48.87 US$6,451